Christoph Zielinski

1. KRZAKOWSKI, Maciej, WENCZL, M., BRODOWICZ, T., TZEKOVA, V., RAMLAU, R., GHILEZAN, N., CUCEVIC, B., ULSPERGER, E., ZIELINSKI, Christoph, ZWITTER, Matjaž. Gemcitabine and cisplatin (GC) +/- subsequent theapy with single-agent gemcitabine in advanced non-small cell lung cancer (NSCLC): preliminary results of a randomized trial of the Central European cooperative. V: ASCO : annual meeting proceedings. New Orleans: American society of clinical oncology, 2004. Str. p7067. [COBISS.SI-ID 19081433]

2. ZIELINSKI, Christoph, ZWITTER, Matjaž, et al. Consensus on medical treatment of non-small-cell lung cancer - update 2004. Lung cancer. [Print ed.]. 2005, letn. 50, št. 1, str. 129-137. ISSN 0169-5002. [COBISS.SI-ID 20349913]

3. ZIELINSKI, Christoph, BEŠLIJA, Semir, MRŠIĆ-KRMPOTIĆ, Zrinka, ČERVEK, Jožica, et al. Gemcitabine, epirubicin, and paclitaxel versus fluorouracil, epirubicin, and cyclophosphamide as first-line chemotherapy in metastatic breast cancer : a Central European cooperative oncology group international, multicenter, prospective, randomized phase III trial. V: 39th Annual Meeting of the American Society of Clinical Oncology, Chicago May 31-June 03, 2003. New York: American Society of Clinical Oncology, 2005. Str. 1401-1408, ilustr. Journal of clinical oncology, vol. 23, issue 7. ISSN 0732-183X. DOI: 10.1200/JCO.2005.12.106. [COBISS.SI-ID 516859161]

4. PETERSON, P., ZWITTER, Matjaž, KRZAKOWSKI, Maciej, WENCZL, M., TZEKOVA, V., RAMLAU, R., CIULEANU, Tudor, LIEPA, A., ZIELINSKI, Christoph, BRODOWICZ, Thomas. Delay in time to worsening of symptoms (TWS) of advanced non-small cell lung cancer (NSCLC) using gemcitabine (gem) maintenance therapy. Journal of clinical oncology. [Print ed.]. 2006, vol. 24, no. 18s, str. 399s, 7140. ISSN 0732-183X. [COBISS.SI-ID 337787]

5. ZIELINSKI, Christoph, AWADA, Ahmad, CAMERON, David A., ČUFER, Tanja, MARTIN, Miguel, AAPRO, Matti S. The impact of new European Organisation for Research and Treatment of Cancer guidelines on the use of granulocyte colony-stimulating factor on the management of breast cancer patients. European Journal of Cancer. [Print ed.]. 2008, vol. 44, no. 3, str. 353-365. ISSN 0959-8049. [COBISS.SI-ID 569467]

6. CIULEANU, Tudor, SCHEITHAUER, W., KURTEVA, G., OCVIRK, Janja, KOZA, I., PAPAMICHAEL, D., WENCZL, M., BRODOWICZ, Thomas, BEŠLIJA, Semir, ZIELINSKI, Christoph. A randomized, open-label phase II study evaluating the efficacy and safety of FOLFOX6 + cetuximab versus FOLFIRI + cetuximab as first-line therapy in patients (pts) with metastatic colorectal cancer (mCRC). V: Science and multidisciplinary management of GI malignancies : proceedings book. Alexandria, VA: American Society of Clinical Oncology, 2008. Str. 238. ISBN 978-1-932312-48-5. [COBISS.SI-ID 590971]

7. MODEST, Dominik P., BRODOWICZ, Thomas, STINTZING, Sebastian, JUNG, Andreas, NEUMANN, Jens, LAUBENDER, R. P., OCVIRK, Janja, KURTEVA, G., PAPAI, Z., KNITTELFELDER, R., KIRCHNER, Thomas, HEINEMANN, Volker, ZIELINSKI, Christoph. Impact of the specific mutation in KRAS codon 12 mutated tumors on treatment efficacy in patients with metastatic colorectal cancer receiving cetuximab-based first-line therapy : a pooled analysis of three trials. Oncology : International Journal of Cancer Research and Treatment. 2012, vol. 83, no. 5, str. 241-247. ISSN 0030-2414. DOI: 10.1159/000339534. [COBISS.SI-ID 1454715]

8. ANGHEL, Rodica, BACHMANN, Alexander, BEKSAC, Meral, BRODOWICZ, Thomas, FINEK, Jindřich, KOMADINA, Radko, KRZEMIENIECKI, Krzysztof, LANG, Istvan, MARENCAK, Jozef, MOOS, Roger von, PECHERSTORFER, Martin, RORDORF, Tamara, VRBANEC, Damir, ZIELINSKI, Christoph. Expert opinion 2011 on the use of new anti-resorptive agents in the prevention of skeletal-related events in metastatic bone disease. Wiener Klinische Wochenschrift. 2013, letn. 125, št. 15-16, str. 439-447. ISSN 0043-5325. [COBISS.SI-ID 605347]

9. THALLINGER, Christiane, LANG, Istvan, GRAŠIČ-KUHAR, Cvetka, BARTSCH, Rupert, SINGER, Christian F., PETRUŽELKA, Luboš, MELICHAR, Bohuslav, KNITTELFELDER, Regina, BRODOWICZ, Thomas, ZIELINSKI, Christoph. Phase II study on the efficacy and safety of Lapatinib administered beyond disease progression and combined with vinorelbine in HER-2/neu- positive advanced breast cancer : results of the CECOG LaVie trial. BMC cancer. Feb. 2016, vol. 16, no. 1, str. 121-1-121-7. ISSN 1471-2407. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758093/pdf/12885_2016_Article_2171.pdf, DOI: 10.1186/s12885-016-2171-y. [COBISS.SI-ID 2276731]

10. RYŠKA, Ales, BUIGA, Rares, FAKIROVA, Albena, KERN, Izidor, OLSZEWSKI, Włodzimierz, PLANK, Lukas, SEIWERTH, Sven, TOTH, Erika, ZIVKA, Eri, THALLINGER, Christiane, ZIELINSKI, Christoph, BRČIĆ, Luka. Non-small cell lung cancer in countries of Central and Southeastern Europe : diagnostic procedures and treatment reimbursement surveyed by the Central European Cooperative Oncology Group. The oncologist. [Online ed.]. Dec. 2018, vol. 23, no. 12, str. e152-e158, tabele. ISSN 1549-490X. http://theoncologist.alphamedpress.org/content/23/12/e152, DiRROS - Digitalni repozitorij raziskovalnih organizacij Slovenije, DOI: 10.1634/theoncologist.2018-0008. [COBISS.SI-ID 2048460913]

11. ČUFER, Tanja, CIULEANU, Tudor, BERZINEC, Peter, GALFFY, Gabriela, JAKOPOVIĆ, Marko, JASSEM, Jacek, JOVANOVIC, Dragana, MIHAYLOVA, Zhasmina, OSTOROS, Gyula, THALLINGER, Christiane, ZEMANOVA, Milada, ZIELINSKI, Christoph. Access to novel drugs for non-small cell lung cancer in Central and Southeastern Europe : a Central European Cooperative Oncology Group analysis. The oncologist. [Online ed.]. Mar. 2020, vol. 25, iss. 3, str. e598-e601, ilustr. ISSN 1549-490X. https://theoncologist.onlinelibrary.wiley.com/doi/epdf/10.1634/theoncologist.2019-0523, DiRROS - Digitalni repozitorij raziskovalnih organizacij Slovenije, DOI: 10.1634/theoncologist.2019-0523. [COBISS.SI-ID 2048592241]

12. RACHEV, Boris, WILKING, Nils, KOBELT, Gisela, SPANDONARO, Federico, RAJER, Mirjana, ROEDIGER, Alexander, NORMAND, Raphaël, ZIELINSKI, Christoph. Budget projections and clinical impact of an immuno-oncology class of treatments : experience in four EU markets. Journal of cancer policy. Jun. 2021, vol. 28, str. 1-7. ISSN 2213-5383. https://www.sciencedirect.com/science/article/pii/S2213538321000102, DOI: 10.1016/j.jcpo.2021.100279. [COBISS.SI-ID 54345475]

13. THALLINGER, Christiane (avtor, korespondenčni avtor), BERZINEC, Peter, BICAKCIC, Emina, DAN, Adelina, FABIAN, Gabriella, GALES, Laurentia Nicoletta, GRAŠIČ-KUHAR, Cvetka, JANŽIČ, Urška, MENCINGER, Marina, ZIELINSKI, Christoph, et al. Establishment of a virtual transborder tumor board for cancer patients in Central and Southeastern Europe : an initiative of the Central European Cooperative Oncology Group (CECOG). Wiener Klinische Wochenschrift. 2022, vol. 134, str. 697–704, ilustr. ISSN 0043-5325. https://link.springer.com/content/pdf/10.1007/s00508-022-02016-z.pdf, DiRROS - Digitalni repozitorij raziskovalnih organizacij Slovenije, DOI: 10.1007/s00508-022-02016-z. [COBISS.SI-ID 102525955]

14. ZIELINSKI, Christoph, ČUFER, Tanja, ŠERUGA, Boštjan, JASSEM, Jacek, DEDIU, Mircea, THALLINGER, Christiane. Perspectives for cancer care and research in Central and Eastern Europe. Oncology research and treatment. 2023, vol. 46, no. 3, str. 80-88. ISSN 2296-5270. https://karger.com/ort/article/46/3/80/835630/Perspectives-for-Cancer-Care-and-Research-in, DOI: 10.1159/000528487. [COBISS.SI-ID 132862467]